Table 2 Factors predictive of mortality and recurrence in univariate and multivariate analyses.
Univariate HR (95%CI) | p-value | Multivariate HR (95%CI) | p-value | |
|---|---|---|---|---|
Mortality | ||||
LAPTM4B-35 high vs. low | 1.34 (0.80–2.24) | 0.256 | N/A | N/A |
Tumor localization | 0.61 (0.36–1.05) | 0.078 | 0.71 (0.37–1.33) | 0.287 |
HPV positive vs. negative | 0.54 (0.25–1.15) | 0.112 | 0.75 (0.31–1.79) | 0.522 |
Sex | 1.14 (0.60–2.16) | 0.671 | N/A | N/A |
Age | 1.05 (0.63–1.78) | 0.826 | N/A | N/A |
T classification | 2.43 (1.41–4.16) | 0.001 | 2.01 (1.12–3.58) | 0.018 |
N classification | 1.41 (0.83–2.39) | 0.196 | 1.47 (0.85–2.54) | 0.168 |
Recurrence | ||||
LAPTM4B-35 high vs. low | 1.92 (1.02–3.59) | 0.041 | 1.7 (0.93–3.32) | 0.082 |
Tumor localization | 0.56 (0.29–1.08) | 0.084 | 0.63 (0.32–1.24) | 0.187 |
HPV positive vs. negative | 0.82 (0.37–1.79) | 0.619 | N/A | N/A |
Sex | 1.52 (0.67–3.48) | 0.313 | N/A | N/A |
Age | 1.01 (0.54–1.90) | 0.954 | N/A | N/A |
T classification | 1.62 (0.81–3.24) | 0.167 | 1.36 (0.67–2.77) | 0.383 |
N classification | 1.09 (0.58–2.05) | 0.765 | N/A | N/A |